Doing medicine investment needs to do a good job of "tracking" services

In today's increasingly fierce drug investment industry, although "tracking" is considered the most stupid method, the tracking strategy will not get much applause, but it is very effective for drug investment enterprises. Tracking companies can make better innovations and surpasses in tracking. In fact, the tracking strategy plays a role all the time. Choosing a benchmark and the choice of market competitors is very important. We must choose a stronger and more powerful opponent than ourselves as our own reference, so that we can make great progress. Therefore, Pharmaceutical investment needs to do a good job of "tracking" services.

First of all, when many well-known pharmaceutical investment companies do pharmaceutical investment, they have comprehensive information on drug investment, and they generally prefer to use tracking methods. In their words, it is benchmarking. Pull out the model companies or competitive enterprises of service companies and systematically decompose them. Start with the three core perspectives of production, sales, and research, supplemented by deeper factors such as management, culture, systems, and talents. In addition to discovering that there are not enough companies, pharmaceutical investment companies can also track their peer companies and look beyond their competitors in order to form new core values ​​for their own businesses.

Secondly, pay attention to the details of the work of investment in pharmaceuticals. The focus on details is the key to success or failure of investment. Merchants should have product introductions, marketing solutions, analytical data, pharmaceutical investment information, and profitability models. The most crucial point in the details is the model market. If necessary, you must provide the dealer's name and contact information for the model market. This is to earn the trust of the dealer and let him decide the key to the distribution of your product.

Finally, the investment in late-stage investment promotion is a phased work. It can not be endless investment, it will cause people's mistrust. Once the investment is over, they immediately face the sales work; if the business is successful, the service team should be quickly established to provide relevant services; if the drug investment fails, the meeting will be immediately summed up to reduce the greater losses.